Loss of tuberin from cerebral tissues with tuberous sclerosis and astrocytoma

Annals of Neurology

Volumn 40, Issue 6, 1996, Pages 941-944

  Mizuguchi, Masashi ^a,b   Kato, Mitsuhiro ^b   Yamanouchi, Hideo ^b   Ikeda, Kazuhiko ^c   Takashima, Sachio ^b  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MEMBRANE PROTEIN;

ADOLESCENT; ADULT; ARTICLE; ASTROCYTOMA; BRAIN TISSUE; CELL FRACTIONATION; CHILD; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GRAY MATTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCHEMISTRY; NEUROPATHOLOGY; PRIORITY JOURNAL; TUBEROUS SCLEROSIS;

ADOLESCENT; ADULT; ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; FEMALE; GENE EXPRESSION; HUMANS; REPRESSOR PROTEINS; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 0030497352     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410400621     Document Type: Article

References (10)

1. Carbonara C, Longa L, Grosso E, et al. 9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene. Hum Mol Genet 1994;3:1829-1832
2. Green AJ, Smith M, Yates JRY. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nature Genet 1994;6:193-196
3. The European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993;75:1305-1315
4. Wienecke R, König A, DeClue JE. Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap 1GAP activity. J Biol Chem 1995;270:16409-16414
5. Mizuguchi M, Takashima S, Kakita A, et al. Lissencephaly gene product. Localization in the central nervous system and loss of immunoreactivity in Miller-Dicker syndrome. Am J Pathol 1995;147:1142-1151
6. Iwasaki Y, Yoshikawa H, Sasaki M, et al. Clinical and immunohistochemical studies of subependymal giant cell astrocytomas associated with tuberous sclerosis. Brain Dev 1990;12: 478-481
7. Pleasure SJ, Page C, Lee VMY. Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J Neurosci 1992;12:1802-1815
8. Takeshita I, Bigner S, Liou J, et al. A thymidine-kinase deficient 5-bromo 2′ deoxyuridine resistant human glioma-derived permanent cell line that expresses glial fibrillary acidic protein. J Neuropathol Exp Neurol 1981;40:336 (Abstract)
9. Mizuguchi M, Ikeda K, Asada M, et al. Expression of Bcl-2 protein in murine glial cells in culture. Brain Res 1994;649: 197-202
10. Xu L, Sterner C, Maheshwar MM, et al. Alternative splicing of the tuberous sclerosis 2 (TSC2) gene in human and mouse tissues. Genomics 1995;27:475-480